iShares S&P 500 Growth

Most Recent

  • uploads///Histogram
    Macroeconomic Analysis

    What New Developments Can You Expect from the Fed?

    Potential new developments from the Fed include a suggestion by the subcommittee on communications that median values of policymakers’ projections be published.

    By David Ashworth
  • uploads///Graph
    Company & Industry Overviews

    Behind Amgen’s Plans to Penetrate the Migraine Segment

    Amgen and Novartis are exploring an investigational drug that is a CGRP antibody, AMG 334, for the treatment of episodic and chronic migraine headaches.

    By Margaret Patrick
  • uploads///strensiq
    Earnings Report

    Inside Alexion’s Metabolic Drugs Kanuma and Strensiq

    In 1Q16, Strensiq added $33.2 million to Alexion Pharmaceuticals’ top line. Now the drug is in its initial launch phase in the US, Germany, and Japan.

    By Jillian Dabney
  • uploads///Part
    Company & Industry Overviews

    Nike Market Share Gets the High Score in Activewear

    UA’s market share came in at 6%, and ADDYY’s came in at 3%. Hanes (HBI) took 3% of the market in 1Q15 .Nike (NKE) was the market leader for activewear overall.

    By Phalguni Soni
  • uploads///genvoya
    Company & Industry Overviews

    How Could TAF-Based Regimen Drive Gilead Sciences’s Growth?

    Gilead Sciences’s (GILD) TAF-based (tenofovir alafenamide) regimen comprises three products: Genvoya, Descovy, and Odefsey.

    By Jillian Dabney
  • uploads///Portfolio Composition of US Large Cap Equity Mutual Funds
    Company & Industry Overviews

    US Large-Cap Equity Funds: Is Active or Passive Investment Best?

    Except for one fund (MIGFX), no other actively managed fund that we have reviewed in this series has been able to outperform the passively managed SPY.

    By David Ashworth
  • uploads///MNST valuation
    Consumer

    Assessing Monster Beverage’s Valuation before 2Q16 Results

    Monster Beverage (MNST) was trading at a 12-month forward PE (price-to-earnings) ratio of 36.6x as of July 25.

    By Sirisha Bhogaraju
  • uploads///RTD Starbucks
    Company & Industry Overviews

    PepsiCo Partners with Starbucks to Seek Growth in Latin America

    In 2016, PepsiCo and Starbucks will distribute Starbucks’s ready-to-drink, or RTD, coffee and energy beverages in select Latin American markets.

    By Sirisha Bhogaraju
  • uploads///Part
    Company & Industry Overviews

    Home Depot: Strong Growth Outlook for 2016

    Based on Home Depot’s 2016 outlook, full-year revenues would range between $86.1 and $87.1 billion, up from $83.2 billion last year.

    By Phalguni Soni
  • uploads///Portfolio Composition of US Large Cap Equity Mutual Funds
    Basic Materials

    What to Do with Your US Large-Cap Mutual Funds Now?

    Even amid uncertainty in markets, it’s wise to stay with your US large-cap mutual funds. If it hasn’t been doing well, study its past before deciding.

    By David Ashworth
  • uploads///Part
    Company & Industry Overviews

    North America: The Critical Market For Under Armour

    In 2013, the company had 117 factory-house stores and 6 brand stores in North America. Store rollout is up and is expected to be stronger going forward.

    By Phalguni Soni
  • uploads///
    Fund Managers

    JAT Capital Exits Stake in Comcast

    In its fourth-quarter 13F, JAT Capital revealed that it had sold its stake in Comcast (CMCSA).

    By Santiago Solari
  • uploads///Part
    Consumer

    Productivity Enhancements: How Home Depot Is Trimming the Fat

    Productivity enhancements resulted in improved profitability margins for the world’s number one retailer.

    By Phalguni Soni
  • uploads///Part
    Company & Industry Overviews

    A Look at the Details of Home Depot’s Digital Update

    Home Depot has been following a strategy that leverages its brick-and-mortar store network and digital capabilities to create a seamless shopper experience.

    By Phalguni Soni
  • uploads///Part
    Consumer

    How Much Has Under Armour Increased Revenue Guidance?

    Under Armour raised the higher end of its 2016 operating income estimate to $503 million–$507 million, implying a growth rate of 23.1%–24.1% over 2015.

    By Phalguni Soni
  • uploads///Part
    Company & Industry Overviews

    Foot Locker’s Opportunities in Growing Apparel Business

    Foot Locker’s (FL) emphasis on growing (IVW) its women’s business will likely be tied to the growth of its apparel products.

    By Phalguni Soni
  • uploads///Part
    Company & Industry Overviews

    Why Is Foot Locker Eyeing Higher Growth in Europe?

    Foot Locker (FL) made about 28.4% of its sales, or $2.1 billion, from outside the United States in fiscal 2016.

    By Phalguni Soni
  • uploads///Part
    Consumer

    The Catalysts Powering Nike’s Growth Performance in Fiscal 2016

    Nike (NKE) is expected to post sales of $8.3 billion in fiscal 4Q16, an increase of 6.4% year-over-year, according to the Wall Street analysts’ consensus.

    By Phalguni Soni
  • uploads///proj pe ratio
    Consumer

    Total Returns and Sector Exposure for Growth Indexes—Continued

    The S&P 900 Growth and S&P 900 Pure Growth indexes have three-year annualized returns of 13% and 9.7%, respectively.

    By Amanda Lawrence
  • uploads///Chart
    Company & Industry Overviews

    How Incyte’s Jakafi Performed in 3Q17

    Incyte’s (INCY) oncology drug Jakafi (ruxolitinib) is approved for the treatment of myelofibrosis and polycythemia vera, two rare types of blood cancer.

    By Mike Benson
  • uploads///heartlogic
    Company & Industry Overviews

    New Data Confirms the Efficiency of BSX’s HeartLogic Diagnostic

    On September 19, 2017, Boston Scientific announced new data from its MultiSENSE (Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients) study.

    By Sarah Collins
  • uploads///
    Macroeconomic Analysis

    Will the S&P 500 Index Rally beyond 2,500?

    The S&P 500 Index (SPY) closed the week ending September 15 at 2,500.23, gaining 1.6% as compared to the previous week’s close.

    By Ricky Cove
  • uploads///
    Macroeconomic Analysis

    The Week Ahead for the S&P 500 Index

    The S&P 500 Index (SPY) closed at 2,461.43 for the week ended September 8, 2017, falling 0.61% compared to the previous week’s close.

    By Ricky Cove
  • uploads///
    Macroeconomic Analysis

    Could North Korea’s New Nuclear Test Drag S&P 500 Lower?

    The S&P 500 Index (SPY) closed the week ended September 1, 2017, at 2,476.5, rising 1.3% compared to its close for the week ended August 25, 2017.

    By Ricky Cove
  • uploads///STRATEGY
    Company & Industry Overviews

    Boston Scientific’s Expansion Plans in a Fast-Growing Market

    Boston Scientific (BSX) has been shifting its focus away from low-growth markets and is trying to enter the high-growth adjacent markets.

    By Sarah Collins
  • uploads///investments
    Company & Industry Overviews

    Strategic Investments Drive Intuitive Surgical’s Future Growth

    Intuitive Surgical focused on accelerating its strategic investments in recent years. It wants to expand across low-cost and untapped markets.

    By Sarah Collins
  • uploads///
    Macroeconomic Analysis

    What Could Move the S&P 500 Index This Week?

    The S&P 500 Index (SPY) closed the week ending August 25 at 2,443.05 and rose 0.72%—compared to the close on August 11.

    By Ricky Cove
  • uploads///Southwest airlines analyst ratings
    Company & Industry Overviews

    What Do Analysts Recommend for Southwest Airlines?

    Of the 17 analysts tracking Southwest Airlines (LUV), six analysts have a “strong buy” recommendation on the stock, and another six analysts have a “buy” recommendation. The remaining five analysts have a “hold” rating.

    By Ally Schmidt
  • uploads///Southwest airlines capacity
    Company & Industry Overviews

    Southwest Airlines’s Capacity Growth Slows Down

    In February 2017, Southwest Airlines’s (LUV) capacity grew 1.2% year-over-year to 11.0 billion miles. This is significantly lower than the previous month’s 6.2% YoY growth.

    By Ally Schmidt
  • uploads///Graph
    Company & Industry Overviews

    AbbVie’s Venclexta May Become Promising Multiple Myeloma Therapy

    AbbVie (ABBV) and Roche Holdings (RHHBY) have completed a Phase 1 trial evaluating the use of Venclexta as a therapy for multiple myeloma patients.

    By Margaret Patrick
  • uploads///segments
    Company & Industry Overviews

    Trial Data Affirms Positive Results of HeartLogic Diagnostic Service

    Developed by Boston Scientific (BSX), HeartLogic is a system of sensors that can be attached to defibrillator devices. These sensors can monitor the patient and predict heart failure events.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    AbbVie’s Plans for ABT-555, a Novel Multiple Sclerosis Therapy

    AbbVie (ABBV) is currently researching investigational therapy ABT-555 for neuroprotection and neuroregeneration in patients with multiple sclerosis.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    AbbVie’s HCV Regimen Gets Breakthrough Therapy Designation

    On September 30, 2016, AbbVie’s (ABBV) investigational next-generation hepatitis C virus (or HCV) regimen received breakthrough therapy designation from the FDA.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Phase 3 Trials Show Elagolix’s Efficacy for Endometriosis Pain

    AbbVie (ABBV) and Neurocrine Biosciences (NBIX) have completed two phase 3 trials to evaluate the efficacy and safety of Elagolix as a treatment option for reducing pain associated with endometriosis as compared to a placebo.

    By Margaret Patrick
  • uploads///MITG
    Earnings Report

    Here’s What’s Driving Medtronic’s MITG Segment

    Of Medtronic’s ~$7.3 billion in worldwide revenues in fiscal 2Q17, ~$2.5 billion came from Medtronic’s MITG segment, representing ~34% of the company’s total revenues.

    By Sarah Collins
  • uploads///ctg
    Company & Industry Overviews

    Exploring the Nuances of Stryker’s Cost Transformation for Growth

    Cost transformation growth is one of Stryker’s key strategies for driving growth. The company has come a long way from its decentralized structure prior to 2010.

    By Sarah Collins
  • uploads///Fund Flows
    Company & Industry Overviews

    Bernstein: Excess Risk Aversion Has Made Investors ‘Wallflowers’

    In his November Insights newsletter, Richard Bernstein stated, “It is incredible that investors have basically been wallflowers during the second longest bull market of the post-war period.”

    By David Ashworth
  • uploads///Change in the Federal Funds Rate
    Macroeconomic Analysis

    How the Next President Could Shape US Monetary Policy

    The Federal Reserve’s second last meeting of 2016 is now over, leaving only one meeting left in which the central bank can enact a rate hike.

    By David Ashworth
  • uploads///Graph
    Company & Industry Overviews

    Medivation Adds Leading Prostate Cancer Drug Xtandi to Pfizer’s Oncology Portfolio

    On September 28, 2016, Pfizer (PFE) announced the completion of its acquisition of Medivation for around $14 billion.

    By Margaret Patrick
  • uploads///Portfolio Composition of US Large Cap Equity Mutual Funds
    Company & Industry Overviews

    How Should Fund Investors Approach the US Presidential Election and the Fed’s Impending Rate Hike?

    If you’ve reached your investment horizon and have seen substantial gains, it would be wise to liquidate or reallocate to more conservative funds.

    By David Ashworth
  • uploads///Profit GDP
    Company & Industry Overviews

    What’s Fueling the Bull Run? Richard Bernstein Explains

    A bull run with legs In Richard Bernstein Advisors’ October Insights newsletter, after dismissing the belief that the Federal Reserve is to blame for stock price inflation (IWD) (VTV), Richard Bernstein moved on to explain the reason for the current bull run. Stating that “fundamentals have improved dramatically, and have been a major support to the […]

    By David Ashworth
  • uploads///Yield Movement Before and During Taper Tantrum
    Macroeconomic Analysis

    Why Were Fed Policymakers Worried about Clear Communication?

    The credibility of the Federal Reserve was a concern raised by some policymakers at the September FOMC (Federal Open Market Committee) meeting.

    By David Ashworth
  • uploads///
    Earnings Report

    How Chipotle Plans to Expand Its Business

    Current operations By the end of 2Q16, Chipotle Mexican Grill (CMG) operated 2,078 Chipotle restaurants in the United States, 14 in Canada, seven in England, five in France, and one in Germany. Also, the company operates 15 ShopHouse Southeast Asian Kitchen restaurants and four Pizzeria Locale restaurants. 3Q16 estimates In 3Q16, Wall Street analysts are expecting […]

    By Rajiv Nanjapla
  • uploads///HIV US market
    Company & Industry Overviews

    How GILD Plans to Battle through Impending HIV Patent Cliff

    Gilead Sciences (GILD) is the leading biotechnology player in the global HIV market.

    By Sarah Collins
  • uploads///discovy and odefsey
    Company & Industry Overviews

    Descovy and Odefsey: Gilead Sciences’ Recently Approved TAF-Based Products

    Gilead Sciences (GILD) recently launched three TAF-based (tenofovir alafenamide) STRs (single-tablet regimens), including Genvoya, Descovy, and Odefsey.

    By Jillian Dabney
  • uploads///
    Earnings Report

    Yum! Brands Raises Its Dividend for 3Q16

    On September 26, 2016, Yum! Brands’ (YUM) board announced that it would pay a dividend of $0.51 in 3Q16.

    By Rajiv Nanjapla
  • uploads///FRS Assets
    Macroeconomic Analysis

    Why Does the September 2016 Dissent in the FOMC Matter?

    Eric Rosengren is generally considered to be a dove, meaning that he has favored monetary accommodation in the US.

    By David Ashworth
  • uploads///sovaldi patients
    Company & Industry Overviews

    How Gilead Dominates the HCV Space

    In January 2012, Gilead Sciences (GILD) acquired Pharmasset and got access to sofosbuvir. In December 2013, the FDA approved sofosbuvir under the brand name Sovaldi.

    By Jillian Dabney
  • uploads///Graph
    Company & Industry Overviews

    How Multiple Research Programs in Lung Cancer Space Are Impacting Bristol-Myers Squibb

    Bristol-Myers Squibb (BMY) is currently involved in a broad registrational program made up of multiple Phase 3 clinical trials to develop Opdivo

    By Margaret Patrick
  • uploads///ONETOUCH
    Company & Industry Overviews

    Johnson & Johnson’s Latest Medical Device Launches

    Johnson & Johnson has announced the schedule for the launch of the OneTouch Via insulin patch. It plans to launch the device in select US markets by the end of 2016.

    By Sarah Collins
  • uploads///segment performance
    Earnings Report

    Analyzing Medtronic’s Sales Growth by Segment in 1Q17

    Medtronic (MDT) operates under four segments: Cardiac and Vascular Group (or CVG), Minimally Invasive Therapies Group (or MITG), Restorative Therapies Group (or RTG), and Diabetes Group.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    CELG’s Otezla Continues Dominating US Inflammation and Immunology

    Celgene’s (CELG) inflammation and immunology drug Otezla has been witnessing strong demand both in the United States and in other new markets in Europe.

    By Margaret Patrick
  • uploads///bd medical
    Earnings Report

    Becton Dickinson’s BD Medical Segment Sales in Fiscal 3Q16

    Becton, Dickinson and Company, or BD (BDX), reported ~$3.2 billion in worldwide revenue in fiscal 3Q16. Of that, ~$2.2 billion was generated by BD Medical, a segment that contributed ~70% to BD’s total revenues.

    By Sarah Collins
  • uploads///guidance
    Earnings Report

    Behind Alexion’s Updated Guidance for Its Metabolic Franchise

    During the second quarter of 2016, Alexion (ALXN) witnessed 23% volume growth, resulting in an 18% annual revenue growth.

    By Jillian Dabney
  • uploads///Fund Flows
    Company & Industry Overviews

    Equities Are Out of Favor, Bonds Are In: Fund Flow Data

    From December 2014 to June 2016, funds for US equities have seen outflows of $176 billion. Bond funds have seen inflows worth the same quantum.

    By David Ashworth
  • uploads///ppi
    Company & Industry Overviews

    Can Thermo Fisher’s PPI Business System Continue to Drive Growth in 2016?

    The PPI system has helped nourish strong top-line growth across Thermo Fisher’s businesses while boosting margins.

    By Sarah Collins
  • uploads///cvg structure
    Company & Industry Overviews

    What Drives Medtronic’s Cardiac Vascular Group’s Revenues?

    Medtronic’s (MDT) Cardiac and Vascular Group (or CVG) is its largest segment.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Understanding Trinity: Inside the Testing of AbbVie’s Rova-T

    Trinity is a phase-2 clinical trial that tests the use of Rova-T as a third-line therapy for SCLC (small cell lung cancer).

    By Margaret Patrick
  • uploads///daccdecffcefbcceadfcd
    Company & Industry Overviews

    Why Is the PE Ratio Important to a Bull Market?

    An assessment of a bull market isn’t complete without looking at the companies’ PE ratios. Generally, the ratio rises during a bull market.

    By David Ashworth
  • uploads///analyst recommendations
    Earnings Report

    What Do Analysts Recommend for Medtronic ahead of 4Q16 Results?

    In a Bloomberg survey of 26 brokerage companies on May 26, 2016, about 81% of analysts rated Medtronic as a “buy,” and 19% rated it as a “hold.”

    By Sarah Collins
  • uploads///NAB volume
    Earnings Report

    PepsiCo’s Non-Carbonated Beverages Sparkle in 1Q16

    In 1Q16, PepsiCo’s North America Beverages segment accounted for 36.8% of the company’s net revenue and 27.5% of the division’s total operating profit.

    By Sirisha Bhogaraju
  • uploads///EL e commerce
    Fund Managers

    The Lowdown on Colgate’s Online Initiatives in Personal and Home Care

    In Brazil, 70% of women are in the range of 18–49 years old, and Colgate has a lower CPM (cost per thousand) than TV for this group—60% of the cost.

    By Penny Morgan
  • uploads///PepsiCos health
    Macroeconomic Analysis

    New Beverage Options: All in the Name of Health and Wellness

    Food and nonalcoholic beverage companies have been focusing on new products that cater to consumers’ health and wellness needs.

    By Sirisha Bhogaraju
  • uploads///off price inventory turnover ratio
    Company & Industry Overviews

    Why Off-Price Retailers Are Managing Inventory Better than Department Stores

    Efficient inventory management is one of the key attributes of off-price retailers like TJX Companies (TJX) and Ross Stores (ROST).

    By Sirisha Bhogaraju
  • uploads///Graph
    Company & Industry Overviews

    Romosozumab: Will It Benefit Amgen in the Future?

    In 1Q16, Amgen expects to have data from its Phase 3 clinical trial exploring the use of innovative drug romosozumab for treating post-menopausal osteoporosis.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    New Pan-Genotypic HCV Drug Should Create Growth Opportunities

    Despite strong competition posed by AbbVie, Merck, and Johnson & Johnson, Gilead Sciences is expected to continue its stronghold in the HCV space in 2016.

    By Margaret Patrick
  • uploads///part
    Company & Industry Overviews

    Apple Watch Revenues Expected to Be $8.4 Billion for First Year

    The average selling price for the Apple Watch is expected to be $400 in its first 12 months, and shipments are expected to reach 21 million units.

    By Adam Rogers
  • uploads///Graph
    Earnings Report

    AbbVie Advanced Its Mid- and Late-Stage Research Pipeline in 3Q15

    AbbVie (ABBV) has a strong oncology research pipeline, involving drugs such as Imbruvica, Elotuzumab, Veliparib, and ABT-199 (or Venetoclax).

    By Margaret Patrick
  • uploads///medsurg
    Company & Industry Overviews

    Breaking down Stryker’s MedSurg Segment

    Stryker’s MedSurg segment reported an increase of 10.8% in net sales in 2014, driven by increased demand in instruments, medical products, and acquisitions.

    By Sarah Collins
  • uploads///Series  A
    Company & Industry Overviews

    What Is Amazon’s Strategy behind Selling Semiconductors?

    After being a successful web retailer for years, Amazon tried to branch out into manufacturing its own products with the launch of “Fire Phone.”

    By Puja Tayal
  • uploads///geographic segmentationn
    Company & Industry Overviews

    Understanding the Geographical Segmentation of Stryker

    While Stryker is a global medical tech company focused on expanding its presence across international markets, the US makes up ~68% of its total revenues.

    By Sarah Collins
  • uploads///Comcast DMA
    Company & Industry Overviews

    Competitive Landscape of Comcast Cable

    Comcast Cable faces stiff competition for its triple play services, that is, its video, voice, and HSI (high-speed Internet) services.

    By Shirley Pelts
  • uploads///part
    Company & Industry Overviews

    Amazon Faces off with Google in Cloud and Online Shopping

    Amazon will now be not only facing competition from retailers like Target and Wal-Mart but also facing off with Alphabet, Google’s parent company.

    By Adam Rogers
  • uploads///KO advertising expenses
    Company & Industry Overviews

    Understanding Coca-Cola’s New Marketing Efforts

    Coca-Cola (KO) is using its productivity savings to ramp up its media investments.

    By Sirisha Bhogaraju
  • uploads///JWN online sales
    Earnings Report

    Nordstrom’s 3Q15 Online Business Continues to Look Promising

    Nordstrom has online channels in its full-line and in the off-price businesses. The company’s Nordstrom.com website caters to the full-line consumers.

    By Sirisha Bhogaraju
  • uploads///MNST segments
    Earnings Report

    Why Monster Gained from Coca-Cola’s Energy Drink Brands in 3Q15

    With the completion of its strategic deal with Coca-Cola (KO) in June 2015, Monster Beverage’s energy drinks portfolio expanded to include Coca-Cola’s energy drink brands.

    By Sirisha Bhogaraju
  • uploads///Graph
    Earnings Report

    Celgene Has a Strong Inflammation and Immunology Pipeline

    In 3Q15, Celgene had a strong inflammation and immunology pipeline. The company witnessed the progress of its key investigational drug GED-0301.

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    Why Amgen’s Valuation Multiples Remained Stable

    We compare a company’s valuation multiples to its peers to find the best-priced valuation. But real valuation doesn’t give us a full picture of the entire sector.

    By Margaret Patrick
  • uploads///Rost store footprint
    Company & Industry Overviews

    Understanding Ross Stores’ Business Model

    Ross Stores operates under two trademarks: Ross Dress for Less and dd’s DISCOUNTS. There are 1,259 Dress for Less and 165 dd’s DISCOUNTS stores in the US.

    By Sirisha Bhogaraju
  • uploads///Grooming and Hair care
    Macroeconomic Analysis

    P&G’s Grooming and Hair Care Brands Lead Market

    P&G’s Gillette, Fusion, and Venus are its largest male and female grooming brands. It has continued to grow with ProGlide and FlexBall in the US.

    By Penny Morgan
  • uploads///Swot
    Company & Industry Overviews

    Obstacles to Altria Group’s Growth: Weaknesses and Threats

    Altria’s business faces threats of high scrutiny, taxation, and regulation. Prohibitions on cigarette sales and smoking bans in public places affect sales.

    By Penny Morgan
  • uploads///Fabric care
    Macroeconomic Analysis

    Colgate’s Efforts to Engage Consumers to Build Brand Awareness

    In order to attract consumers in retail stores, Colgate has increased its commercial investment in advertising, promotions, trade spending, and creative brand building.

    By Penny Morgan
  • uploads///Part
    Earnings Report

    Overseas Markets and Nike: Obstacles on the Leading Footwear Company’s Revenue Racetrack?

    In fiscal 2015, Nike derived ~55% of its sales from overseas markets—18.7% from Western Europe, 12.7% from Emerging Markets, and 10% from Greater China.

    By Phalguni Soni
  • uploads///Sports broadcasting rights
    Company & Industry Overviews

    Disney’s ESPN: Revenues under Competitive Pressure

    ESPN is a part of Disney’s Media Networks segment. Affiliate fees are major component of this segment and are under pressure due to subscriber loss.

    By Shirley Pelts
  • uploads///Famous Brands
    Company & Industry Overviews

    A Closer Look at the Altria Group’s Brand Stable

    Altria’s brands include Marlboro, Copenhagen, Skoal, Black & Mild, and MarkTen, plus wines like Ste. Michelle, Columbia Crest, 14 Hands, and Stag’s Leap.

    By Penny Morgan
  • uploads///PM Innovation
    Company & Industry Overviews

    Philip Morris’s New Innovative Products in the Reduced-Risk Tobacco Market

    Philip Morris now develops innovative products for adult smokers based on new technologies and trends. It aims to use reduced-risk products to compete.

    By Penny Morgan
  • uploads///cefdcdee
    Company & Industry Overviews

    Philip Morris’s Dominant Positioning in a Tough Industry

    Tobacco regulations make entry into the industry difficult. Different brands and substitutes pose threats, but Philip Morris keeps prices reasonable.

    By Penny Morgan
  • uploads///EL swot
    Company & Industry Overviews

    Assessing Estée Lauder’s Strengths and Opportunities

    Estée Lauder’s large geographical footprint diversifies its revenue stream, which is one of its chief strengths.

    By Penny Morgan
  • uploads///EL capex
    Company & Industry Overviews

    Analyzing Why Estée Lauder’s Capital Expenditure Is Rising

    Estée Lauder’s net cash flow from investing activities for fiscal 2014 came in at $0.51 billion in fiscal 2014, compared to $0.46 billion in fiscal 2013.

    By Penny Morgan
  • uploads///EL heritage brands
    Company & Industry Overviews

    Estée Lauder’s Most Promising Brands

    Catering to the premium market, Estee Lauder’s heritage brands include Aramis and Designer Fragrances, Clinique, and Origins.

    By Penny Morgan
  • uploads///Part
    Earnings Report

    VF’s Jeanswear and Sportswear Segments See Mixed Trends

    VF’s jeanswear revenue was flat year-over-year at $608 million in 2Q15. Wrangler saw sales in the Americas grow in the mid-single digits.

    By Phalguni Soni
  • uploads///Part
    Macroeconomic Analysis

    Home Depot’s Online Ticket Size Soars Past In-Store Spending

    The ticket size for Home Depot’s online sales is significantly higher than the average in-store spend of $55–$65 per transaction.

    By Phalguni Soni
  • uploads///Part
    Earnings Report

    Under Armour’s Valuation Hits All-Time Record

    Valuations for Under Armour (UA) have been spiking lately. The company’s valuation reached a new record of 78.2x forward earnings on April 16.

    By Phalguni Soni
  • uploads///ISM Manufacturing PMI
    Macroeconomic Analysis

    ISM Manufacturing Index Fell for the Fifth Month in a Row

    The report for March 2015 showed that the ISM PMI in the US fell to 51.5%. It was down from 52.9% in February. The average for the last year was 55.5%.

    By David Ashworth
  • uploads///Part
    Company & Industry Overviews

    Discovering VF Corp.’s Marketing Edge

    VFC’s marketing dollars are designed to get the most returns from its stores, other retailers (wholesale customers), and its e-commerce websites.

    By Phalguni Soni
  • uploads///Part
    Earnings Report

    Expanding Product Platforms Drive Armour’s Revenue Gains

    Under Armour’s footwear revenues grew 41.8% to $0.3 billion in Q1–Q3 2014. Under Armour is a much newer entrant in the NIKE-dominated footwear space.

    By Phalguni Soni
  • uploads///US Construction Spending
    Macroeconomic Analysis

    Where did construction spending rise and fall?

    As the name suggests, construction spending shows how much money is being spent on new construction in the US. The report is released with a lag.

    By David Ashworth
  • uploads///Part
    Earnings Report

    Back-To-School, Black Friday Boost NIKE Footwear Sales

    Running shoes remain the company’s largest footwear category. NIKE reported mid to high single-digit growth worldwide in this category.

    By Phalguni Soni
  • uploads///Part
    Company & Industry Overviews

    Under Armour’s Cost Profile And Outlook

    Under Armour, Inc.’s cost of goods sold margins have been fairly steady over the years. SG&A costs are likely to trend higher in the near to medium term.

    By Phalguni Soni
  • uploads///Part
    Company & Industry Overviews

    Under Armour Versus NIKE: Can David Beat The Footwear Goliath?

    Who’s winning the footwear races? Under Armour, Inc. (UA) began selling footwear products in 2006. Since then, footwear sales have grown impressively, increasing to 15.8% of revenues, or $345.2 million, in the first three quarters of 2014. Footwear sales grew by over 30% year-over-year in all three quarters. Market leadership Under Armour, or UA, first entered […]

    By Phalguni Soni
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.